NASDAQ: SCHL
SCHOLASTIC CORPCIK 0000866729 · SIC 2731 · Books
Mid
Revenue $1.6B
Assets $1.7B
as of Oct 18, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (FPS 10-K) is open in full — no account needed.
10-Q
Filed Sep 25, 2026
· Period ending Aug 31, 2026
Red flag
Scholastic Q1 revenue falls 3.9% to $216.8M; net loss widens to -$71.2M
5 material changes detected. Sign up free to read the summary.
8-K
Filed Sep 24, 2026
· Period ending Sep 24, 2026
Summary not yet generated.
Partner
Trade SCHL commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
8-K
Filed Sep 21, 2026
· Period ending Sep 16, 2026
Summary not yet generated.
8-K
Filed Aug 27, 2026
· Period ending Aug 27, 2026
Summary not yet generated.
10-K
Filed Jul 24, 2026
· Period ending May 31, 2026
Summary not yet generated.
8-K
Filed Jul 23, 2026
· Period ending Jul 23, 2026
Summary not yet generated.
10-Q
Filed Mar 20, 2026
· Period ending Feb 28, 2026
Summary not yet generated.
8-K
Filed Mar 19, 2026
· Period ending Mar 19, 2026
Summary not yet generated.
8-K
Filed Mar 19, 2026
· Period ending Mar 19, 2026
Summary not yet generated.
10-Q
Filed Dec 19, 2025
· Period ending Nov 30, 2025
Summary not yet generated.
10-Q
Filed Sep 19, 2025
· Period ending Aug 31, 2025
Summary not yet generated.
10-K
Filed Jul 25, 2025
· Period ending May 31, 2025
Summary not yet generated.
10-K/A
Filed Sep 30, 2024
· Period ending May 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Sep 25, 2026 (period ending Aug 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(Dollar amounts in millions, except per share data)
| Description | Three months ended August 31, 2026 | Three months ended August 31, 2025 |
|---|---|---|
| Revenues | 216.8 | 225.6 |
| Operating costs and expenses: | ||
| Cost of goods sold | 118.1 | 123.5 |
| Selling, general and administrative expenses | 178.3 | 177.2 |
| Depreciation and amortization | 12.6 | 16.3 |
| Asset impairments and write downs | — | 0.8 |
| Total operating costs and expenses | 309.0 | 317.8 |
| Operating income (loss) | (92.2) | (92.2) |
| Interest income (expense), net | (1.6) | (4.5) |
| Other components of net periodic benefit (cost) | 0.1 | (0.3) |
| Earnings (loss) before income taxes | (93.7) | (97.0) |
| Provision (benefit) for income taxes | (22.5) | (25.9) |
| Net income (loss) | (71.2) | (71.1) |
| Basic and diluted earnings (loss) per share of Class A and Common Stock | ||
| Basic | (3.77) | (2.83) |
| Diluted | (3.77) | (2.83) |
Condensed Consolidated Balance Sheets (Unaudited)
(Dollar amounts in millions, except per share data)
| Description | August 31, 2026 (unaudited) | May 31, 2026 (audited) | August 31, 2025 (unaudited) |
|---|---|---|---|
| ASSETS | |||
| Current Assets: | |||
| Cash and cash equivalents | 106.8 | 134.9 | 94.3 |
| Accounts receivable, net | 186.6 | 236.4 | 187.0 |
| Inventories, net | 315.3 | 265.0 | 322.2 |
| Income tax receivable | 50.9 | 28.4 | 35.3 |
| Tax credit receivable | 17.3 | 19.3 | 19.0 |
| Prepaid expenses and other current assets | 53.3 | 37.3 | 72.4 |
| Total current assets | 730.2 | 721.3 | 730.2 |
| Noncurrent Assets: | |||
| Property, plant and equipment, net | 200.5 | 201.6 | 512.5 |
| Prepublication costs, net | 40.1 | 41.1 | 48.9 |
| Investment in film and television programs, net | 37.8 | 40.4 | 44.6 |
| Operating lease right-of-use assets, net | 287.5 | 291.2 | 97.9 |
| Royalty advances, net | 63.8 | 64.6 | 81.6 |
| Goodwill | 199.2 | 199.4 | 199.7 |
| Other intangible assets, net | 74.8 | 77.9 | 86.6 |
| Noncurrent deferred income taxes | 31.9 | 31.8 | 34.5 |
| Other assets and deferred charges | 59.5 | 58.8 | 118.1 |
| Total noncurrent assets | 995.1 | 1,006.8 | 1,224.4 |
| Total assets | 1,725.3 | 1,728.1 | 1,954.6 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| Current Liabilities: | |||
| Lines of credit and current portion of long-term debt | 9.8 | 5.5 | 6.2 |
| Film related obligations | 19.3 | 17.1 | 14.7 |
| Accounts payable | 150.2 | 144.2 | 175.8 |
| Accrued royalties | 68.0 | 50.3 | 86.6 |
| Deferred revenue | 171.6 | 179.2 | 181.0 |
| Other accrued expenses | 129.8 | 158.1 | 138.5 |
| Accrued income taxes | 4.7 | 4.7 | 1.9 |
| Operating lease liabilities | 29.5 | 26.4 | 26.7 |
| Total current liabilities | 582.9 | 585.5 | 631.4 |
| Noncurrent Liabilities: | |||
| Long-term debt | 175.0 | 75.0 | 325.0 |
| Operating lease liabilities | 276.1 | 280.6 | 85.3 |
| Other noncurrent liabilities | 34.8 | 36.2 | 34.9 |
| Total noncurrent liabilities | 485.9 | 391.8 | 445.2 |
| Commitments and Contingencies (see Note 6) | — | — | — |
| Stockholders’ Equity: | |||
| Preferred Stock, $1.00 par value: Authorized, 2.0 shares; Issued and Outstanding, none | — | — | — |
| Class A Stock, $0.01 par value: Authorized, 3.2 shares; Issued and Outstanding, 0.8 shares | 0.0 | 0.0 | 0.0 |
| Common Stock, $0.01 par value: Authorized, 70.0 shares; Issued, 42.9 shares; Outstanding, 17.6, 17.9, and 24.3 shares, respectively | 0.4 | 0.4 | 0.4 |
| Additional paid-in capital | 601.6 | 602.5 | 607.9 |
| Accumulated other comprehensive income (loss) | (37.1) | (35.9) | (37.7) |
| Retained earnings | 961.5 | 1,037.6 | 923.5 |
| Treasury stock, at cost: 25.3, 25.0 and 18.6 shares, respectively | (869.9) | (853.8) | (616.1) |
| Total stockholders’ equity | 656.5 | 750.8 | 878.0 |
| Total liabilities and stockholders’ equity | 1,725.3 | 1,728.1 | 1,954.6 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Dollar amounts in millions)
| Description | Three months ended August 31, 2026 | Three months ended August 31, 2025 |
|---|---|---|
| Cash flows - operating activities: | ||
| Net income (loss) | (71.2) | (71.1) |
| Adjustments to reconcile Net income (loss) to net cash provided by (used in) operating activities: | ||
| Provision for losses on accounts receivable | 0.6 | 0.7 |
| Provision for losses on inventory | 3.3 | 3.9 |
| Provision for losses on royalty advances | 1.0 | 0.9 |
| Amortization of prepublication costs | 4.9 | 5.4 |
| Amortization of film and television programs | 4.2 | 1.7 |
| Depreciation and amortization | 15.9 | 19.4 |
| Amortization of pension and postretirement plans | (0.1) | 0.2 |
| Deferred income taxes | (0.1) | 0.2 |
| Stock-based compensation | 2.2 | 1.9 |
| Income from equity-method investments | 0.0 | 0.1 |
| Non cash write off related to asset impairments and write downs | — | 0.8 |
| Changes in assets and liabilities, net of amounts acquired: | ||
| Accounts receivable | 49.3 | 86.1 |
| Inventories | (53.7) | (75.6) |
| Income tax receivable | (22.5) | (26.6) |
| Tax credit receivable | 1.9 | 2.0 |
| Prepaid expenses and other current assets | (16.9) | (24.4) |
| Investment in film and television programs | (2.3) | (3.7) |
| Royalty advances | (0.2) | (4.3) |
| Accounts payable | 5.9 | 18.2 |
| Accrued royalties | 17.7 | 17.3 |
| Deferred revenue | (7.4) | 2.0 |
| Other accrued expenses | (26.1) | (26.0) |
| Accrued income taxes | 0.0 | (1.8) |
| Other, net | (1.0) | (9.1) |
| Net cash provided by (used in) operating activities | (94.6) | (81.8) |
| Cash flows - investing activities: | ||
| Prepublication expenditures | (4.0) | (4.9) |
| Additions to property, plant and equipment | (14.1) | (10.0) |
| Net proceeds from sale of investments | 0.7 | — |
| Other, net | 0.1 | — |
| Net cash provided by (used in) investing activities | (17.3) | (14.9) |
| Cash flows - financing activities: | ||
| Borrowings under lines of credit and long-term debt | 104.3 | 78.0 |
| Repayments of lines of credit and long-term debt | — | (2.9) |
| Borrowings under film related obligations | 4.5 | 5.1 |
| Repayments of film related obligations (including interest) | (2.6) | (8.6) |
| Repayments of capital lease obligations | (1.2) | (0.5) |
| Reacquisition of common stock | (25.3) | — |
| Proceeds pursuant to stock-based compensation plans | 8.0 | 0.9 |
| Payment of dividends | (3.8) | (5.2) |
| Net cash provided by (used in) financing activities | 83.9 | 66.8 |
| Effect of exchange rate changes on cash and cash equivalents | (0.1) | 0.2 |
| Net increase (decrease) in cash and cash equivalents | (28.1) | (29.7) |
| Cash and cash equivalents at beginning of period | 134.9 | 124.0 |
| Cash and cash equivalents at end of period | 106.8 | 94.3 |
Amounts as printed on the EDGAR/iXBRL face — (Dollar amounts in millions, except per share data); (Dollar amounts in millions). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗